Global Smart Pills Market was valued US$ 0.781 Bn in 2017 and is expected to reach US$ 2.234 Bn by 2026, at a CAGR of 14.04 % during a forecast period. The smart pills market is segmented into an application, target area, disease indication, end user, and region. In terms of application, smart pills market is segmented into capsule endoscopy, drug delivery, and patient monitoring. Based on target area segment, smart pills market is classified into the esophagus, small intestine, large intestine, and stomach. Further disease indication, smart pills market is divided into esophageal diseases, small bowel diseases, colon diseases, and others. In terms of the end user, smart pills market is classified into the hospital, diagnostic center, and research institute. Based on regions, the smart pills market is divided into five main regions are North America, Europe, Asia-pacific, Latin America and Middle East & Africa.
In terms of application, capsule endoscopy accounted the largest share in terms of revenue due to the increased sophistication in endoscopy procedures is projected to propel the growth of the global capsule endoscopy market. Apart from this, patient monitoring segment is projected to upright an outstanding CAGR during the forecast period. Based on the target area, the small intestine target area accounted for the highest revenue and is expected to maintain its dominance throughout the forecast period.
This is attributed to the significant increase in small intestinal disorders such as Crohn’s disease, celiac disease, and small bowel tumors. The major driving factor of the smart pills market has increased the difficulty in endoscopy procedures, controlled drug delivery, easy remote patient monitoring scenario across the globe, patient preference for minimally invasive procedures, and rising prevalence of colon cancer. Technological incompetence of capsule endoscopes, high costs, and fear among patients regarding swallowing a microchip are limiting the growth of the global smart pills market. Additionally, poor adaptation of technology is also the main factor that restrains the global smart pills market.
Technological advancements, such as microprocessors, micro-camera, micro-sensors, and others, are predicted to create lucrative opportunities in the future. Geographically, The Asia Pacific market commanded the largest share of thel smart pills market due to the increasing reimbursements, training in endoscopes handling, and huge corporate investments in R&D in countries is driving the growth of the global smart pills market. The key player operating in global smart pills market are Proteus Digital Health, HQ, Inc., CapsoVision, Inc., Medtronic Plc., Olympus Corporations, IntroMedic Co., Ltd, RF Co., Ltd, JINSHAN Science & Technology, Check-Cap, and Koninklijke Philips N.V.
Scope of Global Smart Pills Market:
• Capsule Endoscopy • Drug Delivery • Patient Monitoring
• Esophagus • Small Intestine • Large Intestine • Stomach
• Esophageal Diseases • Small Bowel Diseases • Colon Diseases • Others
• Hospital • Diagnostic Center • Research Institute
• North America • Europe • Middle East & Africa • Asia Pacific • Latin America
The key player operating in Global Smart Pills Market:
• Proteus Digital Health • HQ, Inc. • CapsoVision, Inc. • Medtronic Plc. • Olympus Corporations • IntroMedic Co. • Ltd, RF Co. • Ltd, JINSHAN Science & Technology • Check-Cap • Koninklijke Philips N.V.
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Smart Pills Market Size, by Market Value (US$ Bn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Global Smart Pills Market Analysis and Forecast 5.1. Global Smart Pills Market Analysis and Forecast 5.2. Global Smart Pills Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Smart Pills Market Analysis and Forecast, by Application 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Smart Pills Market Value Share Analysis, by Application 6.4. Global Smart Pills Market Size (US$ Bn) Forecast, by Application 6.5. Global Smart Pills Market Analysis, by Application 6.6. Global Smart Pills Market Attractiveness Analysis, by Application 7. Global Smart Pills Market Analysis and Forecast, By Target Area 7.1. Introduction and Definition 7.2. Global Smart Pills Market Value Share Analysis, By Target Area 7.3. Global Smart Pills Market Size (US$ Bn) Forecast, By Target Area 7.4. Global Smart Pills Market Analysis, By Target Area 7.5. Global Smart Pills Market Attractiveness Analysis, By Target Area 8. Global Smart Pills Market Analysis and Forecast, by Disease Indication 8.1. Introduction and Definition 8.2. Global Smart Pills Market Value Share Analysis, by Disease Indication 8.3. Global Smart Pills Market Size (US$ Bn) Forecast, by Disease Indication 8.4. Global Smart Pills Market Analysis, by Disease Indication 8.5. Global Smart Pills Market Attractiveness Analysis, by Disease Indication 9. Global Smart Pills Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Global Smart Pills Market Value Share Analysis, by End User 9.3. Global Smart Pills Market Size (US$ Bn) Forecast, by End User 9.4. Global Smart Pills Market Analysis, by End User 9.5. Global Smart Pills Market Attractiveness Analysis, by End User 10. Global Smart Pills Market Analysis, by Region 10.1. Global Smart Pills Market Value Share Analysis, by Region 10.2. Global Smart Pills Market Size (US$ Bn) Forecast, by Region 10.3. Global Smart Pills Market Attractiveness Analysis, by Region 11. North America Smart Pills Market Analysis 11.1. Key Findings 11.2. North America Smart Pills Market Overview 11.3. North America Smart Pills Market Value Share Analysis, by Application 11.4. North America Smart Pills Market Forecast, by Application 11.4.1. Capsule Endoscopy 11.4.2. Drug Delivery 11.4.3. Patient Monitoring 11.5. North America Smart Pills Market Value Share Analysis, By Target Area 11.6. North America Smart Pills Market Forecast, By Target Area 11.6.1. Esophagus 11.6.2. Small Intestine 11.6.3. Large Intestine 11.6.4. Stomach 11.7. North America Smart Pills Market Value Share Analysis, by Disease Indication 11.8. North America Smart Pills Market Forecast, by Disease Indication 11.8.1. Esophageal Diseases 11.8.2. Small Bowel Diseases 11.8.3. Colon Diseases 11.8.4. Others 11.9. North America Smart Pills Market Value Share Analysis, by End User 11.10. North America Smart Pills Market Forecast, by End User 11.10.1. Hospital 11.10.2. Diagnostic Center 11.10.3. Research Institute 11.11. North America Smart Pills Market Value Share Analysis, by Country 11.12. North America Smart Pills Market Forecast, by Country 11.12.1. U.S. 11.12.2. Canada 11.13. North America Smart Pills Market Analysis, by Country 11.14. U.S. Smart Pills Market Forecast, by Application 11.14.1. Capsule Endoscopy 11.14.2. Drug Delivery 11.14.3. Patient Monitoring 11.15. U.S. Smart Pills Market Forecast, By Target Area 11.15.1. Esophagus 11.15.2. Small Intestine 11.15.3. Large Intestine 11.15.4. Stomach 11.16. U.S. Smart Pills Market Forecast, by Disease Indication 11.16.1. Esophageal Diseases 11.16.2. Small Bowel Diseases 11.16.3. Colon Diseases 11.16.4. Others 11.17. U.S. Smart Pills Market Forecast, by End User 11.17.1. Hospital 11.17.2. Diagnostic Center 11.17.3. Research Institute 11.18. Canada Smart Pills Market Forecast, by Application 11.18.1. Capsule Endoscopy 11.18.2. Drug Delivery 11.18.3. Patient Monitoring 11.19. Canada Smart Pills Market Forecast, By Target Area 11.19.1. Esophagus 11.19.2. Small Intestine 11.19.3. Large Intestine 11.19.4. Stomach 11.20. Canada Smart Pills Market Forecast, by Disease Indication 11.20.1. Esophageal Diseases 11.20.2. Small Bowel Diseases 11.20.3. Colon Diseases 11.20.4. Others 11.21. Canada Smart Pills Market Forecast, by End User 11.21.1. Hospital 11.21.2. Diagnostic Center 11.21.3. Research Institute 11.22. North America Smart Pills Market Attractiveness Analysis 11.22.1. By Application 11.22.2. By Target Area 11.22.3. By Disease Indication 11.22.4. By End User 11.23. PEST Analysis 12. Europe Smart Pills Market Analysis 12.1. Key Findings 12.2. Europe Smart Pills Market Overview 12.3. Europe Smart Pills Market Value Share Analysis, by Application 12.4. Europe Smart Pills Market Forecast, by Application 12.4.1. Capsule Endoscopy 12.4.2. Drug Delivery 12.4.3. Patient Monitoring 12.5. Europe Smart Pills Market Value Share Analysis, By Target Area 12.6. Europe Smart Pills Market Forecast, By Target Area 12.6.1. Esophagus 12.6.2. Small Intestine 12.6.3. Large Intestine 12.6.4. Stomach 12.7. Europe Smart Pills Market Value Share Analysis, by Disease Indication 12.8. Europe Smart Pills Market Forecast, by Disease Indication 12.8.1. Esophageal Diseases 12.8.2. Small Bowel Diseases 12.8.3. Colon Diseases 12.8.4. Others 12.9. Europe Smart Pills Market Value Share Analysis, by End User 12.10. Europe Smart Pills Market Forecast, by End User 12.10.1. Hospital 12.10.2. Diagnostic Center 12.10.3. Research Institute 12.11. Europe Smart Pills Market Value Share Analysis, by Country 12.12. Europe Smart Pills Market Forecast, by Country 12.12.1. Germany 12.12.2. U.K. 12.12.3. France 12.12.4. Italy 12.12.5. Spain 12.12.6. Rest of Europe 12.13. Europe Smart Pills Market Analysis, by Country/ Sub-region 12.14. Germany Smart Pills Market Forecast, by Application 12.14.1. Capsule Endoscopy 12.14.2. Drug Delivery 12.14.3. Patient Monitoring 12.15. Germany Smart Pills Market Forecast, By Target Area 12.15.1. Esophagus 12.15.2. Small Intestine 12.15.3. Large Intestine 12.15.4. Stomach 12.16. Germany Smart Pills Market Forecast, by Disease Indication 12.16.1. Esophageal Diseases 12.16.2. Small Bowel Diseases 12.16.3. Colon Diseases 12.16.4. Others 12.17. Germany Smart Pills Market Forecast, by End User 12.17.1. Hospital 12.17.2. Diagnostic Center 12.17.3. Research Institute 12.18. U.K. Smart Pills Market Forecast, by Application 12.18.1. Capsule Endoscopy 12.18.2. Drug Delivery 12.18.3. Patient Monitoring 12.19. U.K. Smart Pills Market Forecast, By Target Area 12.19.1. Esophagus 12.19.2. Small Intestine 12.19.3. Large Intestine 12.19.4. Stomach 12.20. U.K. Smart Pills Market Forecast, by Disease Indication 12.20.1. Esophageal Diseases 12.20.2. Small Bowel Diseases 12.20.3. Colon Diseases 12.20.4. Others 12.21. U.K. Smart Pills Market Forecast, by End User 12.21.1. Hospital 12.21.2. Diagnostic Center 12.21.3. Research Institute 12.22. France Smart Pills Market Forecast, by Application 12.22.1. Capsule Endoscopy 12.22.2. Drug Delivery 12.22.3. Patient Monitoring 12.23. France Smart Pills Market Forecast, By Target Area 12.23.1. Esophagus 12.23.2. Small Intestine 12.23.3. Large Intestine 12.23.4. Stomach 12.24. France Smart Pills Market Forecast, by Disease Indication 12.24.1. Esophageal Diseases 12.24.2. Small Bowel Diseases 12.24.3. Colon Diseases 12.24.4. Others 12.25. France Smart Pills Market Forecast, by End User 12.25.1. Hospital 12.25.2. Diagnostic Center 12.25.3. Research Institute 12.26. Italy Smart Pills Market Forecast, by Application 12.26.1. Capsule Endoscopy 12.26.2. Drug Delivery 12.26.3. Patient Monitoring 12.27. Italy Smart Pills Market Forecast, By Target Area 12.27.1. Esophagus 12.27.2. Small Intestine 12.27.3. Large Intestine 12.27.4. Stomach 12.28. Italy Smart Pills Market Forecast, by Disease Indication 12.28.1. Esophageal Diseases 12.28.2. Small Bowel Diseases 12.28.3. Colon Diseases 12.28.4. Others 12.29. Italy Smart Pills Market Forecast, by End User 12.29.1. Hospital 12.29.2. Diagnostic Center 12.29.3. Research Institute 12.30. Spain Smart Pills Market Forecast, by Application 12.30.1. Capsule Endoscopy 12.30.2. Drug Delivery 12.30.3. Patient Monitoring 12.31. Spain Smart Pills Market Forecast, By Target Area 12.31.1. Esophagus 12.31.2. Small Intestine 12.31.3. Large Intestine 12.31.4. Stomach 12.32. Spain Smart Pills Market Forecast, by Disease Indication 12.32.1. Esophageal Diseases 12.32.2. Small Bowel Diseases 12.32.3. Colon Diseases 12.32.4. Others 12.33. Spain Smart Pills Market Forecast, by End User 12.33.1. Hospital 12.33.2. Diagnostic Center 12.33.3. Research Institute 12.34. Rest of Europe Smart Pills Market Forecast, by Application 12.34.1. Capsule Endoscopy 12.34.2. Drug Delivery 12.34.3. Patient Monitoring 12.35. Rest of Europe Smart Pills Market Forecast, By Target Area 12.35.1. Esophagus 12.35.2. Small Intestine 12.35.3. Large Intestine 12.35.4. Stomach 12.36. Rest of Europe Smart Pills Market Forecast, by Disease Indication 12.36.1. Esophageal Diseases 12.36.2. Small Bowel Diseases 12.36.3. Colon Diseases 12.36.4. Others 12.37. Rest Of Europe Smart Pills Market Forecast, by End User 12.37.1. Hospital 12.37.2. Diagnostic Center 12.37.3. Research Institute 12.38. Europe Smart Pills Market Attractiveness Analysis 12.38.1. By Application 12.38.2. By Target Area 12.38.3. By Disease Indication 12.38.4. By End User 12.39. PEST Analysis 13. Asia Pacific Smart Pills Market Analysis 13.1. Key Findings 13.2. Asia Pacific Smart Pills Market Overview 13.3. Asia Pacific Smart Pills Market Value Share Analysis, by Application 13.4. Asia Pacific Smart Pills Market Forecast, by Application 13.4.1. Capsule Endoscopy 13.4.2. Drug Delivery 13.4.3. Patient Monitoring 13.5. Asia Pacific Smart Pills Market Value Share Analysis, By Target Area 13.6. Asia Pacific Smart Pills Market Forecast, By Target Area 13.6.1. Esophagus 13.6.2. Small Intestine 13.6.3. Large Intestine 13.6.4. Stomach 13.7. Asia Pacific Smart Pills Market Value Share Analysis, by Disease Indication 13.8. Asia Pacific Smart Pills Market Forecast, by Disease Indication 13.8.1. Esophageal Diseases 13.8.2. Small Bowel Diseases 13.8.3. Colon Diseases 13.8.4. Others 13.9. Asia Pacific Smart Pills Market Value Share Analysis, by End User 13.10. Asia Pacific Smart Pills Market Forecast, by End User 13.10.1. Hospital 13.10.2. Diagnostic Center 13.10.3. Research Institute 13.11. Asia Pacific Smart Pills Market Value Share Analysis, by Country 13.12. Asia Pacific Smart Pills Market Forecast, by Country 13.12.1. China 13.12.2. India 13.12.3. Japan 13.12.4. ASEAN 13.12.5. Rest of Asia Pacific 13.13. Asia Pacific Smart Pills Market Analysis, by Country/ Sub-region 13.14. China Smart Pills Market Forecast, by Application 13.14.1. Capsule Endoscopy 13.14.2. Drug Delivery 13.14.3. Patient Monitoring 13.15. China Smart Pills Market Forecast, By Target Area 13.15.1. Esophagus 13.15.2. Small Intestine 13.15.3. Large Intestine 13.15.4. Stomach 13.16. China Smart Pills Market Forecast, by Disease Indication 13.16.1. Esophageal Diseases 13.16.2. Small Bowel Diseases 13.16.3. Colon Diseases 13.16.4. Others 13.17. China Smart Pills Market Forecast, by End User 13.17.1. Hospital 13.17.2. Diagnostic Center 13.17.3. Research Institute 13.18. India Smart Pills Market Forecast, by Application 13.18.1. Capsule Endoscopy 13.18.2. Drug Delivery 13.18.3. Patient Monitoring 13.19. India Smart Pills Market Forecast, By Target Area 13.19.1. Esophagus 13.19.2. Small Intestine 13.19.3. Large Intestine 13.19.4. Stomach 13.20. India Smart Pills Market Forecast, by Disease Indication 13.20.1. Esophageal Diseases 13.20.2. Small Bowel Diseases 13.20.3. Colon Diseases 13.20.4. Others 13.21. India Smart Pills Market Forecast, by End User 13.21.1. Hospital 13.21.2. Diagnostic Center 13.21.3. Research Institute 13.22. Japan Smart Pills Market Forecast, by Application 13.22.1. Capsule Endoscopy 13.22.2. Drug Delivery 13.22.3. Patient Monitoring 13.23. Japan Smart Pills Market Forecast, By Target Area 13.23.1. Esophagus 13.23.2. Small Intestine 13.23.3. Large Intestine 13.23.4. Stomach 13.24. Japan Smart Pills Market Forecast, by Disease Indication 13.24.1. Esophageal Diseases 13.24.2. Small Bowel Diseases 13.24.3. Colon Diseases 13.24.4. Others 13.25. Japan Smart Pills Market Forecast, by End User 13.25.1. Hospital 13.25.2. Diagnostic Center 13.25.3. Research Institute 13.26. ASEAN Smart Pills Market Forecast, by Application 13.26.1. Capsule Endoscopy 13.26.2. Drug Delivery 13.26.3. Patient Monitoring 13.27. ASEAN Smart Pills Market Forecast, By Target Area 13.27.1. Esophagus 13.27.2. Small Intestine 13.27.3. Large Intestine 13.27.4. Stomach 13.28. ASEAN Smart Pills Market Forecast, by Disease Indication 13.28.1. Esophageal Diseases 13.28.2. Small Bowel Diseases 13.28.3. Colon Diseases 13.28.4. Others 13.29. ASEAN Smart Pills Market Forecast, by End User 13.29.1. Hospital 13.29.2. Diagnostic Center 13.29.3. Research Institute 13.30. Rest of Asia Pacific Smart Pills Market Forecast, by Application 13.30.1. Capsule Endoscopy 13.30.2. Drug Delivery 13.30.3. Patient Monitoring 13.31. Rest of Asia Pacific Smart Pills Market Forecast, By Target Area 13.31.1. Esophagus 13.31.2. Small Intestine 13.31.3. Large Intestine 13.31.4. Stomach 13.32. Rest of Asia Pacific Smart Pills Market Forecast, by Disease Indication 13.32.1. Esophageal Diseases 13.32.2. Small Bowel Diseases 13.32.3. Colon Diseases 13.32.4. Others 13.33. Rest of Asia Pacific Smart Pills Market Forecast, by End User 13.33.1. Hospital 13.33.2. Diagnostic Center 13.33.3. Research Institute 13.34. Asia Pacific Smart Pills Market Attractiveness Analysis 13.34.1. By Application 13.34.2. By Target Area 13.34.3. By Disease Indication 13.34.4. By End User 13.35. PEST Analysis 14. Middle East & Africa Smart Pills Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Smart Pills Market Overview 14.3. Middle East & Africa Smart Pills Market Value Share Analysis, by Application 14.4. Middle East & Africa Smart Pills Market Forecast, by Application 14.4.1. Capsule Endoscopy 14.4.2. Drug Delivery 14.4.3. Patient Monitoring 14.5. Middle East & Africa Smart Pills Market Value Share Analysis, By Target Area 14.6. Middle East & Africa Smart Pills Market Forecast, By Target Area 14.6.1. Esophagus 14.6.2. Small Intestine 14.6.3. Large Intestine 14.6.4. Stomach 14.7. Middle East & Africa Smart Pills Market Value Share Analysis, by Disease Indication 14.8. Middle East & Africa Smart Pills Market Forecast, by Disease Indication 14.8.1. Esophageal Diseases 14.8.2. Small Bowel Diseases 14.8.3. Colon Diseases 14.8.4. Others 14.9. Middle East & Africa Smart Pills Market Value Share Analysis, by End User 14.10. Middle East & Africa Smart Pills Market Forecast, by End User 14.10.1. Hospital 14.10.2. Diagnostic Center 14.10.3. Research Institute 14.11. Middle East & Africa Smart Pills Market Value Share Analysis, by Country 14.12. Middle East & Africa Smart Pills Market Forecast, by Country 14.12.1. GCC 14.12.2. South Africa 14.12.3. Rest of Middle East & Africa 14.13. Middle East & Africa Smart Pills Market Analysis, by Country/ Sub-region 14.14. GCC Smart Pills Market Forecast, by Application 14.14.1. Capsule Endoscopy 14.14.2. Drug Delivery 14.14.3. Patient Monitoring 14.15. GCC Smart Pills Market Forecast, By Target Area 14.15.1. Esophagus 14.15.2. Small Intestine 14.15.3. Large Intestine 14.15.4. Stomach 14.16. GCC Smart Pills Market Forecast, by Disease Indication 14.16.1. Esophageal Diseases 14.16.2. Small Bowel Diseases 14.16.3. Colon Diseases 14.16.4. Others 14.17. GCC Smart Pills Market Forecast, by End User 14.18. Hospital 14.19. Diagnostic Center 14.20. Research Institute 14.21. Others South Africa Smart Pills Market Forecast, by Application 14.21.1. Capsule Endoscopy 14.21.2. Drug Delivery 14.21.3. Patient Monitoring 14.22. South Africa Smart Pills Market Forecast, By Target Area 14.22.1. Esophagus 14.22.2. Small Intestine 14.22.3. Large Intestine 14.22.4. Stomach 14.23. South Africa Smart Pills Market Forecast, by Disease Indication 14.23.1. Esophageal Diseases 14.23.2. Small Bowel Diseases 14.23.3. Colon Diseases 14.23.4. Others 14.24. South Africa Smart Pills Market Forecast, by End User 14.24.1. Hospital 14.24.2. Diagnostic Center 14.24.3. Research Institute 14.25. Rest of Middle East & Africa Smart Pills Market Forecast, by Application 14.25.1. Capsule Endoscopy 14.25.2. Drug Delivery 14.25.3. Patient Monitoring 14.26. Rest of Middle East & Africa Smart Pills Market Forecast, By Target Area 14.26.1. Esophagus 14.26.2. Small Intestine 14.26.3. Large Intestine 14.26.4. Stomach 14.27. Rest of Middle East & Africa Smart Pills Market Forecast, by Disease Indication 14.27.1. Esophageal Diseases 14.27.2. Small Bowel Diseases 14.27.3. Colon Diseases 14.27.4. Others 14.28. Rest of Middle East & Africa Smart Pills Market Forecast, by End User 14.28.1. Hospital 14.28.2. Diagnostic Center 14.28.3. Research Institute 14.29. Middle East & Africa Smart Pills Market Attractiveness Analysis 14.29.1. By Application 14.29.2. By Target Area 14.29.3. By Disease Indication 14.29.4. By End User 14.30. PEST Analysis 15. Latin America Smart Pills Market Analysis 15.1. Key Findings 15.2. Latin America Smart Pills Market Overview 15.3. Latin America Smart Pills Market Value Share Analysis, by Application 15.4. Latin America Smart Pills Market Forecast, by Application 15.4.1. Capsule Endoscopy 15.4.2. Drug Delivery 15.4.3. Patient Monitoring 15.5. Latin America Smart Pills Market Value Share Analysis, By Target Area 15.6. Latin America Smart Pills Market Forecast, By Target Area 15.6.1. Esophagus 15.6.2. Small Intestine 15.6.3. Large Intestine 15.6.4. Stomach 15.7. Latin America Smart Pills Market Value Share Analysis, by Disease Indication 15.8. Latin America Smart Pills Market Forecast, by Disease Indication 15.8.1. Esophageal Diseases 15.8.2. Small Bowel Diseases 15.8.3. Colon Diseases 15.8.4. Others 15.9. Latin America Smart Pills Market Value Share Analysis, by End User 15.10. Latin America Smart Pills Market Forecast, by End User 15.10.1. Hospital 15.10.2. Diagnostic Center 15.10.3. Research Institute 15.11. Latin America Smart Pills Market Value Share Analysis, by Country 15.12. Latin America Smart Pills Market Forecast, by Country 15.12.1. Brazil 15.12.2. Mexico 15.12.3. Rest of Latin America 15.13. Latin America Smart Pills Market Analysis, by Country/ Sub-region 15.14. Brazil Smart Pills Market Forecast, by Application 15.14.1. Capsule Endoscopy 15.14.2. Drug Delivery 15.14.3. Patient Monitoring 15.15. Brazil Smart Pills Market Forecast, By Target Area 15.15.1. Esophagus 15.15.2. Small Intestine 15.15.3. Large Intestine 15.15.4. Stomach 15.16. Brazil Smart Pills Market Forecast, by Disease Indication 15.16.1. Esophageal Diseases 15.16.2. Small Bowel Diseases 15.16.3. Colon Diseases 15.16.4. Others 15.17. Brazil Smart Pills Market Forecast, by End User 15.17.1. Hospital 15.17.2. Diagnostic Center 15.17.3. Research Institute 15.18. Mexico Smart Pills Market Forecast, by Application 15.18.1. Capsule Endoscopy 15.18.2. Drug Delivery 15.18.3. Patient Monitoring 15.19. Mexico Smart Pills Market Forecast, By Target Area 15.19.1. Esophagus 15.19.2. Small Intestine 15.19.3. Large Intestine 15.19.4. Stomach 15.20. Mexico Smart Pills Market Forecast, by Disease Indication 15.20.1. Esophageal Diseases 15.20.2. Small Bowel Diseases 15.20.3. Colon Diseases 15.20.4. Others 15.21. Mexico Smart Pills Market Forecast, by End User 15.21.1. Hospital 15.21.2. Diagnostic Center 15.21.3. Research Institute 15.22. Rest of Latin America Smart Pills Market Forecast, by Application 15.22.1. Capsule Endoscopy 15.22.2. Drug Delivery 15.22.3. Patient Monitoring 15.23. Rest of Latin America Smart Pills Market Forecast, By Target Area 15.23.1. Esophagus 15.23.2. Small Intestine 15.23.3. Large Intestine 15.23.4. Stomach 15.24. Rest of Latin America Smart Pills Market Forecast, by Disease Indication 15.24.1. Esophageal Diseases 15.24.2. Small Bowel Diseases 15.24.3. Colon Diseases 15.24.4. Others 15.25. Rest of Latin America Smart Pills Market Forecast, by End User 15.25.1. Hospital 15.25.2. Diagnostic Center 15.25.3. Research Institute 15.26. Latin America Smart Pills Market Attractiveness Analysis 15.26.1. By Application 15.26.2. By Target Area 15.26.3. By Disease Indication 15.26.4. By End User 15.27. PEST Analysis 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.3. Company Profiles: Key Players 16.3.1. Koninklijke Philips N.V. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Business Strategy 16.3.1.4. Recent Developments 16.3.1.5. Manufacturing Footprint 16.3.2. Proteus Digital Health 16.3.3. HQ, Inc. 16.3.4. CapsoVision, Inc. 16.3.5. Medtronic Plc. 16.3.6. Olympus Corporations 16.3.7. IntroMedic Co., Ltd 16.3.8. RF Co., Ltd 16.3.9. JINSHAN Science & Technology 16.3.10. Check-Cap 17. Primary Key Insights
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
Best quality reports based on various authentic and accurate data findings.
Your personal and confidential information is safe and secure.
Trends Market Research © Copyright 2021. All Rights Reserved.